ErikD.RobersonMDPhD
Neurology • Birmingham, ALNeurodegenerative, Dementia & Geriatrics
Rebecca Gale Endowed Professor; Director, Alzheimer's Disease Center; Director, Center for Neurodegeneration and Experimental Therapeutics
Dr. Roberson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-975-7365
Education & Training
University of California (San Francisco)Residency, Neurology, 2000 - 2003
Baylor College of MedicineInternship, Transitional Year, 1999 - 2000- Baylor College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - Present
AL State Medical License 2008 - 2024- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Start of enrollment: 2012 Dec 01
- Safety Study of TPI-287 to Treat CBS and PSP Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 319 citationsAntiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's DiseaseSarah Mueller-Steiner, Yungui Zhou, Hideaki Arai, Erik D. Roberson, Binggui Sun
Neuron. 2006-09-21 - 1426 citationsCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.Adam C. Naj, Gyungah Jun, Gary W. Beecham, Li-San Wang, Badri N. Vardarajan
Nature Genetics. 2011-05-01 - 733 citationsEarly role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysisYasser Iturria-Medina, Roberto C. Sotero, Paule-Joanne Toussaint, José María Mateos-Pérez, Alan C. Evans
Nature Communications. 2016-06-21
Journal Articles
- Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-Insufficient MiceErik Roberson, MD, ScienceDirect
Press Mentions
Gift Advances Alzheimer’s Disease ResearchJanuary 17th, 2023- $5 Million Gift to UAB Will Support Alzheimer’s Disease ResearchOctober 31st, 2022
- Will Reduction in Tau Protein Protect Against Parkinson’s and Lewy Body Dementias?June 18th, 2021
- Join now to see all
Grant Support
- Mechanisms For The Benefit Of TAU Reduction In Alzheimer Disease ModelsNational Institute Of Neurological Disorders And Stroke2011–2012
- Mechanisms For TAU Involvement In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2008–2010
- Mechanisms For TAU Involvement In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2006–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
